Literature DB >> 17686881

Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey.

Jamie M Zeitzer1, Christine L Buckmaster, David M Lyons, Emmanuel Mignot.   

Abstract

The neuropeptides hypocretins (orexins), the loss of which results in the sleep disorder narcolepsy, are hypothesized to be involved in the consolidation of wakefulness and have been proposed to be part of the circadian-driven alertness signal. To elucidate the role of hypocretins in the consolidation of human wakefulness we examined the effect of wake extension on hypocretin-1 in squirrel monkeys, primates that consolidate wakefulness during the daytime as do humans. Wake was extended up to 7 h with hypocretin-1, cortisol, ghrelin, leptin, locomotion, and feeding, all being assayed. Hypocretin-1 (P < 0.01), cortisol (P < 0.001), and locomotion (P < 0.005) all increased with sleep deprivation, while ghrelin (P = 0.79) and leptin (P = 1.00) did not change with sleep deprivation. Using cross-correlation and multivariate modeling of these potential covariates along with homeostatic pressure (a measure of time awake/asleep), we found that time of day and homeostatic pressure together explained 44% of the variance in the hypocretin-1 data (P < 0.001), while cortisol did not significantly contribute to the overall hypocretin-1 variance. Locomotion during the daytime, but not during the nighttime, helped explain < 5% of the hypocretin-1 variance (P < 0.05). These data are consistent with earlier evidence indicating that in the squirrel monkey hypocretin-1 is mainly regulated by circadian inputs and homeostatic sleep pressure. Concomitants of wakefulness that affect hypocretin-1 in polyphasic species, such as locomotion, food intake, and food deprivation, likely have a more minor role in monophasic species, such as humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686881     DOI: 10.1152/ajpregu.00460.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

Review 1.  Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism.

Authors:  Erin C Hanlon; Eve Van Cauter
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-18       Impact factor: 11.205

2.  Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption.

Authors:  Margaret S Blattner; Sunil K Panigrahi; Cristina D Toedebusch; Terry J Hicks; Jennifer S McLeland; Ian R Banks; Claire Schaibley; Vitaliy Ovod; Kwasi G Mawuenyega; Randall J Bateman; Sharon L Wardlaw; Brendan P Lucey
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  Sleep and metabolic function.

Authors:  Lisa L Morselli; Aurore Guyon; Karine Spiegel
Journal:  Pflugers Arch       Date:  2011-11-19       Impact factor: 3.657

4.  Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey.

Authors:  Jamie M Zeitzer; Tohru Kodama; Christine L Buckmaster; Yoshiko Honda; David M Lyons; Seiji Nishino; Emmanuel Mignot
Journal:  J Sleep Res       Date:  2011-09-13       Impact factor: 3.981

Review 5.  Effects of poor and short sleep on glucose metabolism and obesity risk.

Authors:  Karine Spiegel; Esra Tasali; Rachel Leproult; Eve Van Cauter
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

6.  Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep.

Authors:  Jamie M Zeitzer; Christine L Buckmaster; Hans-Peter Landolt; David M Lyons; Emmanuel Mignot
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

Review 7.  Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.

Authors:  Eliane A Lucassen; Kristina I Rother; Giovanni Cizza
Journal:  Ann N Y Acad Sci       Date:  2012-07-24       Impact factor: 5.691

Review 8.  Sleep and the epidemic of obesity in children and adults.

Authors:  Eve Van Cauter; Kristen L Knutson
Journal:  Eur J Endocrinol       Date:  2008-08-21       Impact factor: 6.664

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.